Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Untangling the Biology of Genetic Cardiomyopathies with Pluripotent Stem Cell Disease Models.

Current cardiology reports - 1 Apr 2017

Buikema Jan W, Wu Sean M

Abstract excerpt

PURPOSE OF REVIEW: Recently, the discovery of strategies to reprogram somatic cells into induced pluripotent stem (iPS) cells has led to a major paradigm change in developmental and stem cell biology. The application of iPS cells and their cardiac progeny has opened novel directions to study cardiomyopathies at a cellular and molecular level. This review discusses approaches currently undertaken to unravel known...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arrhythmogenic Right Ventricular Dysplasia
Share to Cardiomyopathies
Share to Cardiomyopathy, Dilated

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiomyopathy, Hypertrophic

Share to Induced Pluripotent Stem Cells

Share to Mutation

Share to Myocytes, Cardiac

Source

Identifiers

PMID: 28315121
DOI: 10.1007/s11886-017-0842-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Untangling the Biology of Genetic Cardiomyopathies with Pluripotent Stem Cell Disease Models.PMID 28315121Read ↗

Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.Semantic proximity Read ↗

Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic CardiomyopathiesSemantic proximity Read ↗

Concise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem CellsSemantic proximity Read ↗

Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential.Semantic proximity Read ↗

Modeling Inherited Cardiac DisordersSemantic proximity Read ↗

Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cellsSemantic proximity Read ↗

Targeted Therapies in Genetic Dilated and Hypertrophic Cardiomyopathies: From Molecular Mechanisms to Therapeutic Targets. A Position Paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)Semantic proximity Read ↗

Genomic Engineering of Induced Pluripotent Stem Cell-Derived Cardiomyocytes.Semantic proximity Read ↗

Induced pluripotent stem-cell-derived cardiomyocytes: cardiac applications, opportunities, and challenges.Semantic proximity Read ↗

Induced Pluripotent Stem Cells: A New Dawn for the Treatment of Ischemic CardiomyopathySemantic proximity Read ↗

Inherited cardiac diseases, pluripotent stem cells, and genome editing combined—the past, present, and futureSemantic proximity Read ↗

Induced Pluripotent Stem Cells Technology and Cardiomyocyte Generation: Progress, Uncertainties and Challenges in the Biological Features and Clinical ApplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.